|
HOWL Werewolf Therapeutics Inc 1785530 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-13,532,000.00 |
| Balance Sheet |
|
Current Assets
|
$48,734,000.00 |
|
Assets
|
$58,022,000.00 |
|
Current Liabilities
|
$38,519,000.00 |
|
Liabilities
|
$45,820,000.00 |
|
Equity
|
$12,202,000.00 |
|
Shares Out
|
48596817.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-10,597,000.00 |
| Market Analysis |
Market Cap
|
$24,298,408.50 |
|
Price
|
$0.37 |
|
BVPS
|
0.25 |
|
PB
|
2.00 |
|
EPS
|
-0.28 |
|
FCF
|
$-10,597,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
| Apr |
May |
Jun |
| 2026-03-27 |
-0.20 |
|
|
2026-05-07 |
-0.28 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.36 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HOWL documents filed with the SEC.
HOWL Filings
Clear
